The European Commission has approved the proposal of Philip Morris International (PMI) to acquire Swedish Match.
According to a statement on its website, the committee has found that Swedish Match has essentially monopolized the distribution of tobacco and nicotine products in Sweden through its subsidiary, SMD Logistics. The committee's initial investigation indicates that SMD Logistics holds a dominant position in the supply of combustible tobacco, smokeless tobacco, and related products in Sweden.
According to the committee, as SMD is the only distributor of combustible tobacco, smokeless tobacco, and related products in Sweden, this transaction could potentially impact Sweden's competitive landscape. However, the committee did not find any competition issues in other markets where both parties compete, such as the production and supply of snuff in Sweden and Norway and nicotine pouches in Sweden and Slovenia, as there are sufficient alternative suppliers to maintain a competitive market after the transaction.
To overcome preliminary competition concerns, PMI has proposed divesting the logistics division of Swedish Match, called SMD Logistics. These commitments include a structural divestment of the standalone business, completely eliminating vertical links between tobacco and nicotine product manufacturing and distribution in Sweden. This will enable purchasers to operate the divested business as a viable competitive force on a sustainable basis in the market.
The committee stated that it will closely monitor the process of divestment, including the selection of suitable buyers for the divested business, which must receive approval from the committee. After market testing, the committee concluded that the modified transaction, with the commitments made, will no longer raise competition concerns.
Earlier, the acquisition proposal from PMI received approval from authorities in the United States and Brazil.
Jacek Olczak, CEO of PMI, stated in a press release, "We are pleased to have obtained all necessary regulatory approvals and believe that our revised offer for Swedish Match provides significant value for both Swedish Match and PMI shareholders, representing the best and final price.
The revised prices retain 90% of acceptance conditions, which is crucial for maximizing the potential of our portfolio. In case the prices fail, we are prepared to independently develop IQOS and other smokeless products available in the US.
Statement:
This article has been compiled from third-party information and is intended for industry discussion and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is only intended for industry exchange and research.
Due to limitations in the level of translation, the translated article may not fully capture the original meaning. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government's stance and expressions concerning any domestic, Hong Kong, Macau, Taiwan, or foreign issues.
The compilation of information is the property of the original media and author, and if there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
